What sector does Metropolis Healthcare Ltd belong to?

Metropolis Healthcare Ltd operates in the Healthcare sector, specifically the Healthcare Service Provider industry, and is listed on the NSE.

What is the current share price of METROPOLIS?

As of the latest available quote, METROPOLIS traded at ₹585.50. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of METROPOLIS?

Metropolis Healthcare Ltd has a price-to-earnings (P/E) ratio of about 59.87. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of METROPOLIS?

The market capitalisation of Metropolis Healthcare Ltd is approximately ₹12,146 Cr.

Is Metropolis Healthcare Ltd profitable?

For its latest reported financial year, Metropolis Healthcare Ltd recorded a net profit margin of about 11.60%.

Does METROPOLIS pay a dividend?

Metropolis Healthcare Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of METROPOLIS?

Metropolis Healthcare Ltd has a return on equity (ROE) of about 13.60%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of METROPOLIS?

Over the past 52 weeks, METROPOLIS has traded between a low of ₹412.25 and a high of ₹609.05.

Metropolis Healthcare Ltd

METROPOLIS NSE Healthcare Healthcare Service Provider

Microcap 250

₹585.50

-1.70%

Delayed · cached 15 min

Fair value analysis

METROPOLIS

Metropolis Healthcare Ltd

₹595.65

Close used for this calculation

₹298.48Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

42/100

Profitability15/25

Returns6/25

Balance Sheet19/25

Efficiency2/25

Growth3/25

Average

Quality radar

Consensus fair value

₹298.48

Above FV

▼ -49.9% against the close used

Model range ₹87.12 – ₹385.60

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹87.12Fair value₹298.48Bull₹385.60

FairClose

52-week traded range

52W low ₹421.7552W high ₹602.10

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Metropolis Healthcare Ltd closed at ₹595.65, 99.6% above the consensus fair value of ₹298.48 drawn from 9 valuation models.

Financial DNA score 42/100 — Average. P/E of 58.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹292.02

-51.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹129.40

-78.3%

√(22.5 × EPS × BVPS)

EPS=9.17, BVPS=81.15 · outside Graham range (P/E 58.4, P/B 7.3) — asset-light, treat as a rough floor

Graham Formula

₹234.16

-60.7%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=9.5%, FD=7%

P/E Fair Value

₹385.60

-35.3%

EPS × 42.05x (sector P/E)

EPS=9.17, Sector P/E=42.05x

Peter Lynch (PEG)

₹87.12

-85.4%

EPS × Growth% (PEG = 1 is fair)

EPS=9.17, g=9.5%

EV/EBITDA

₹379.23

-36.3%

(EBITDA × 14.8x − Net Debt) ÷ Shares

EBITDA=5.4B

Book Value (P/B)

₹154.19

-74.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=81.15, ROE=13.6%, g=6%, r=10%

Reverse DCF

₹595.65

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 23.1% | Historical: 9.5%

Margin of Safety

₹195.22

-67.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=260.29, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer